Stay updated on Nab-Paclitaxel/Gemcitabine±Olaratumab in Metastatic Pancreatic Ca Clinical Trial
Sign up to get notified when there's something new on the Nab-Paclitaxel/Gemcitabine±Olaratumab in Metastatic Pancreatic Ca Clinical Trial page.

Latest updates to the Nab-Paclitaxel/Gemcitabine±Olaratumab in Metastatic Pancreatic Ca Clinical Trial page
- Check2 days agoNo Change Detected
- Check10 days agoChange DetectedRevision tag on the page updated from v3.6.3 to v3.6.4. This is a backend/system version bump and does not change the study details, eligibility criteria, or any information presented to users.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe page revision tag was updated from v3.6.2 to v3.6.3, indicating a new release iteration. This update affects the page's build/versioning rather than the displayed study details.SummaryDifference0.0%

- Check38 days agoChange DetectedThe page shows an updated revision label from v3.6.0 to v3.6.2, reflecting a newer release of the page rather than changes to study data.SummaryDifference0.0%

- Check53 days agoChange DetectedA recruitment-closed banner 'No longer looking for participants' was added, and new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) appear on the page, along with an updated Intervention/Treatment heading. The old Intervention / Treatment heading was replaced with Intervention/Treatment and the revision tag was updated from v3.5.5 to v3.6.0.SummaryDifference0.3%

- Check60 days agoChange DetectedRevision updated from v3.5.4 to v3.5.5, signaling a software update on the page. No visible study content or layout changes are indicated by the data.SummaryDifference0.0%

- Check81 days agoChange DetectedThe page's revision label changed from v3.5.3 to v3.5.4, indicating a new build of the page. This update reflects a maintenance or version control change rather than a user-visible content modification.SummaryDifference0.0%

Stay in the know with updates to Nab-Paclitaxel/Gemcitabine±Olaratumab in Metastatic Pancreatic Ca Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nab-Paclitaxel/Gemcitabine±Olaratumab in Metastatic Pancreatic Ca Clinical Trial page.